Palisade Bio (PALI) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $5.2 million.
- Palisade Bio's Cash & Current Investments fell 3498.76% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 3498.76%. This contributed to the annual value of $9.8 million for FY2024, which is 2100.23% down from last year.
- Palisade Bio's Cash & Current Investments amounted to $5.2 million in Q3 2025, which was down 3498.76% from $5.4 million recorded in Q2 2025.
- In the past 5 years, Palisade Bio's Cash & Current Investments ranged from a high of $16.4 million in Q2 2023 and a low of $615000.0 during Q1 2021
- Over the past 5 years, Palisade Bio's median Cash & Current Investments value was $11.3 million (recorded in 2024), while the average stood at $10.1 million.
- Data for Palisade Bio's Cash & Current Investments shows a peak YoY increase of 177802.93% (in 2021) and a maximum YoY decrease of 9386.84% (in 2021) over the last 5 years.
- Quarter analysis of 5 years shows Palisade Bio's Cash & Current Investments stood at $14.1 million in 2021, then fell by 12.2% to $12.4 million in 2022, then grew by 0.4% to $12.4 million in 2023, then decreased by 21.0% to $9.8 million in 2024, then crashed by 46.78% to $5.2 million in 2025.
- Its last three reported values are $5.2 million in Q3 2025, $5.4 million for Q2 2025, and $7.2 million during Q1 2025.